Picture of Creo Medical logo

CREO Creo Medical Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m-25.09%
3m-5.55%
6m-10.34%
1yr+7.41%
Volume Change (%)
10d/3m-22.81%
Price vs... (%)
52w High-37%
50d MA-20%
200d MA-7.32%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-36.76%
Return on Equity-38.59%
Operating Margin-96.57%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Creo Medical EPS forecast chart

Profile Summary

Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. It has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes by applying the benefits of advanced laparoscopic surgical technology to areas of therapy where there is significant unmet clinical need. CROMA delivers bipolar radiofrequency energy for precise localized cutting and focused high frequency microwave energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    June 30th, 2023
    Incorporated
    September 12th, 2016
    Public Since
    December 9th, 2016
    No. of Employees
    279
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    gb flag iconLondon Stock Exchange
    Shares in Issue
    361,251,418

    CREO Share Price Performance

    Upcoming Events for CREO

    Full Year 2023 Creo Medical Group PLC Earnings Release

    Creo Medical Group PLC Annual Shareholders Meeting

    Similar to CREO

    Picture of Abingdon Health logo

    Abingdon Health

    gb flag iconLondon Stock Exchange

    Picture of Advanced Medical Solutions logo

    Advanced Medical Solutions

    gb flag iconLondon Stock Exchange

    Picture of Advanced Oncotherapy logo

    Advanced Oncotherapy

    gb flag iconLondon Stock Exchange

    Picture of Angle logo

    Angle

    gb flag iconLondon Stock Exchange

    Picture of Aptamer logo

    Aptamer

    gb flag iconLondon Stock Exchange

    FAQ